LIFE-THREATENING INFECTION IN THIAMAZOLE INDUCED AGRANULOCYTOSIS
A CASE REPORT
Keywords:
thiamazole, PTU, G-CSF, agranulocytosis, sepsisAbstract
CASE
Idiosyncratic antithyroid drug (ATD)-induced neutropenia and agranulocytosis are rare but potentially fatal. Severe sepsis was found in half of the patients, and the mortality rate was 6.7%. Cross-reactive ATD-induced agranulocytosis occurs in 15.2% of cases. A 23-year-old female with a history of Graves’ disease was admitted to the emergency room with abdominal pain and a sore throat. She was on thiamazole treatment for 3 months. There were signs of sepsis and diffuse abdominal pain. Leucocytes were 470/µL and the absolute neutrophil count was 19/µL. This case has been assessed and managed as appendicitis with severe sepsis. Appendicular perforation was discovered during laparotomy exploratory. Propylthiouracil (PTU) was introduced to replace thiamazole and granulocyte colonystimulating factors (GCSF) have been given to shorten the recovery time. Leucocyte counts returned to normal after 14 days of treatment. There was no agranulocytosis crossreaction by PTU. Early diagnosis is essential for proper treatment and a good prognosis.
Downloads
References
*
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Enung Cahya Nurul, Nanny NM Soetedjo, Uun Sumardi, Ervita Ritonga, Maya Kusumawati, Indra Wijaya, Alma Wijaya, Hikmat Permana
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.